Bill C-349 (Historical)

An Act to amend the Patent Act

This bill is from the 39th Parliament, 2nd session, which ended in September 2008.

Sponsor

Introduced as a private member’s bill. (These don’t often become law.)

Status

Outside the Order of Precedence (a private member's bill that hasn't yet won the draw that determines which private member's bills can be debated), as of Oct. 16, 2007
(This bill did not become law.)

Summary

This is from the published bill.

This enactment excludes medicines from the scope of the regulation-making power set out in subsection 55.2(4) of the Patent Act. It makes other amendments to that Act to reduce the extent of patent protection for medicines.
The enactment also repeals the Patented Medicines (Notice of Compliance) Regulations.

Similar bills

C-275 (40th Parliament, 3rd session) An Act to amend the Patent Act (infringement of a patent)

C-275 (40th Parliament, 2nd session) An Act to amend the Patent Act (infringement of a patent)

C-349 (39th Parliament, 1st session) An Act to amend the Patent Act

Elsewhere

All sorts of information on this bill is available at LEGISinfo, an excellent resource from the Library of Parliament. You can also read the full text of the bill.

Bill numbers are reused for different bills each new session. Perhaps you were looking for one of these other C-349s:

C-349 (2023) National Strategy for the Eradication of Rabies Act

C-349 (2017) An Act to amend the Criminal Code and to make consequential amendments to other acts (criminal organization)

C-349 (2013) An Act to amend the Canada Consumer Product Safety Act and the Textile Labelling Act (animal fur or skin)

C-349 (2011) An Act to amend the Canada Consumer Product Safety Act and the Textile Labelling Act (animal fur or skin)

C-349 (2010) An Act to amend the Criminal Code (body armour)

C-349 (2009) An Act to amend the Criminal Code (body armour)

Other House mentions

Patent ActRoutine Proceedings

June 22nd, 2006 / 10:40 a.m.

See context

NDP

Brian Masse NDP Windsor West, ON

moved for leave to introduce Bill C-349, An Act to amend the Patent Act.

Mr. Speaker, this is the second time I have introduced this legislation into the House of Commons.

It deals with patent protection and also the issue of evergreening where legal loopholes extend the patent protection of certain drugs that then cost Canadians significant sums of money, not only to individuals but also in employment benefit plans as well as the organizations that actually provide that across the country.

This will lower drug costs, provide fairness, and make us more similar to the United States. The Americans actually have a more progressive generic drug industry because they have enacted legislation to stop the legal litigation. Most important, it will promote innovation.

(Motions deemed adopted, bill read the first time and printed)